Medical Disposables & Supplies Limited (JMSE:MDS)
Jamaica · Delayed Price · Currency is JMD 1.340
+0.240 (21.82%)
At close: Feb 10, 2026
JMSE:MDS Income Statement
Financials in millions JMD. Fiscal year is April - March.
Millions JMD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 4,006 | 3,884 | 3,709 | 3,770 | 3,416 | 2,423 | |
Revenue Growth (YoY) | 5.50% | 4.71% | -1.60% | 10.35% | 41.01% | -2.35% |
Cost of Revenue | 3,115 | 3,008 | 2,995 | 2,756 | 2,480 | 1,824 |
Gross Profit | 890.69 | 876.43 | 713.9 | 1,014 | 936.46 | 598.89 |
Selling, General & Admin | 883.61 | 867.35 | 844.35 | 783.5 | 670.14 | 480.17 |
Other Operating Expenses | -14.14 | -15.96 | -15.99 | -10.1 | -9.27 | -5.22 |
Operating Expenses | 1,042 | 1,028 | 889.17 | 818 | 714.67 | 504.45 |
Operating Income | -150.91 | -151.66 | -175.27 | 195.72 | 221.8 | 94.45 |
Interest Expense | -153.92 | -153.71 | -159.93 | -104.17 | -71.65 | -70.09 |
Interest & Investment Income | 0.2 | 0.12 | 0.27 | 2.47 | 11.1 | 0.48 |
Currency Exchange Gain (Loss) | 7.41 | 20.92 | 14.4 | 2.87 | -17.97 | -11.04 |
EBT Excluding Unusual Items | -297.22 | -284.33 | -320.51 | 96.89 | 143.28 | 13.8 |
Gain (Loss) on Sale of Assets | 37.39 | - | - | -0.17 | 3.18 | 0.05 |
Other Unusual Items | - | - | - | - | - | 62.09 |
Pretax Income | -259.83 | -284.33 | -320.51 | 96.72 | 146.46 | 75.94 |
Income Tax Expense | -3.27 | -3.27 | -4.55 | 16.52 | 41.03 | 6.32 |
Earnings From Continuing Operations | -256.57 | -281.06 | -315.96 | 80.2 | 105.43 | 69.61 |
Minority Interest in Earnings | 70.52 | 79.23 | 23.87 | -8.06 | -8.47 | - |
Net Income | -186.05 | -201.83 | -292.09 | 72.14 | 96.97 | 69.61 |
Net Income to Common | -186.05 | -201.83 | -292.09 | 72.14 | 96.97 | 69.61 |
Net Income Growth | - | - | - | -25.61% | 39.29% | 101.45% |
Shares Outstanding (Basic) | 264 | 263 | 263 | 263 | 263 | 263 |
Shares Outstanding (Diluted) | 264 | 263 | 263 | 263 | 263 | 263 |
Shares Change (YoY) | -10.91% | - | - | - | - | - |
EPS (Basic) | -0.70 | -0.77 | -1.11 | 0.27 | 0.37 | 0.26 |
EPS (Diluted) | -0.70 | -0.77 | -1.11 | 0.27 | 0.37 | 0.26 |
EPS Growth | - | - | - | -25.61% | 39.29% | 101.45% |
Free Cash Flow | 27.23 | -52.01 | -91.83 | 10.98 | -161.6 | -20.46 |
Free Cash Flow Per Share | 0.10 | -0.20 | -0.35 | 0.04 | -0.61 | -0.08 |
Dividend Per Share | - | - | - | - | 0.090 | 0.070 |
Dividend Growth | - | - | - | - | 28.57% | - |
Gross Margin | 22.23% | 22.56% | 19.25% | 26.89% | 27.41% | 24.72% |
Operating Margin | -3.77% | -3.91% | -4.72% | 5.19% | 6.49% | 3.90% |
Profit Margin | -4.64% | -5.20% | -7.88% | 1.91% | 2.84% | 2.87% |
Free Cash Flow Margin | 0.68% | -1.34% | -2.48% | 0.29% | -4.73% | -0.84% |
EBITDA | -117.07 | -113.25 | -136.43 | 233.65 | 258.7 | 120.92 |
EBITDA Margin | -2.92% | -2.92% | -3.68% | 6.20% | 7.57% | 4.99% |
D&A For EBITDA | 33.84 | 38.41 | 38.84 | 37.93 | 36.9 | 26.48 |
EBIT | -150.91 | -151.66 | -175.27 | 195.72 | 221.8 | 94.45 |
EBIT Margin | -3.77% | -3.91% | -4.72% | 5.19% | 6.49% | 3.90% |
Effective Tax Rate | - | - | - | 17.08% | 28.01% | 8.33% |
Advertising Expenses | - | 62.36 | 77.39 | 58.18 | 43.12 | 28.32 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.